Injectable ART achieves virologic suppression in patients with detectable viral loads and adherence challenges
A study of publicly insured adults living with HIV found that long-acting injectable antiretroviral therapy (LA-ART) with cabotegravir (CAB) and rilpivirine (RPV) achieved virologic suppression among most people with detectable ...
Jul 3, 2023
0
3